Valhi, Inc. (VHI)

ASP Isotopes (NASDAQ: ASPI - Get Free Report) and Valhi (NYSE: VHI - Get Free Report) are both small-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Profitability This table compares ASP Isotopes and

Dallas, Texas, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that, subject to the completion of year-end closing procedures, it expects to report fourth quarter 2025 earnings in a press release after market close on Tuesday, March 10, 2026.

Valhi (NYSE: VHI - Get Free Report) and Olin (NYSE: OLN - Get Free Report) are both basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations and profitability. Analyst Recommendations This is a breakdown of recent ratings

Valhi (NYSE: VHI - Get Free Report) and Sumitomo Chemcl (OTCMKTS:SOMMY - Get Free Report) are both basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Dividends Valhi pays an annual dividend of $0.32

Shares of Valhi, Inc. (NYSE: VHI - Get Free Report) passed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $12.81 and traded as high as $15.02. Valhi shares last traded at $14.7950, with a volume of 32,930 shares changing hands. Wall Street Analyst Weigh

Valhi (NYSE: VHI - Get Free Report) and Albemarle (NYSE: ALB - Get Free Report) are both basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Risk and Volatility Valhi has a beta of 1.18,

Valhi (NYSE: VHI - Get Free Report) and Asahi Kasei (OTCMKTS:AHKSY - Get Free Report) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Analyst Ratings This is a summary of recent

Valhi, Inc. (NYSE: VHI - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $15.31 and traded as low as $11.65. Valhi shares last traded at $11.88, with a volume of 10,027 shares. Wall Street Analyst Weigh

Vitalhub Corp. (TSE: VHI - Get Free Report) was up 0.7% during trading on Tuesday. The company traded as high as C$9.20 and last traded at C$9.14. Approximately 388,970 shares changed hands during mid-day trading, an increase of 145% from the average daily volume of 158,735 shares. The stock had previously closed at C$9.08. Wall

Valhi (VHI) faces headwinds from lower TiO2 prices and destocking on volumes, pressuring its chemical segment despite a positive perimeter effect from a joint venture buyout. Operating income declined due to falling TiO2 prices, stable input costs and general operating leverage on lower industrial volumes. A higher CAPEX commitment and weak market environment have reduced the NAV discount to just 4%.

Koppers (NYSE: KOP - Get Free Report) and Valhi (NYSE: VHI - Get Free Report) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Profitability This table compares Koppers and Valhi's net

Vitalhub Corp. ( VHI:CA ) Q3 2025 Earnings Call November 7, 2025 9:00 AM EST Company Participants Brian Goffenberg - CFO & Executive VP Daniel Matlow - President, CEO & Director Conference Call Participants Gavin Fairweather - Cormark Securities Inc., Research Division Doug Taylor - Canaccord Genuity Corp., Research Division David Kwan - TD Cowen, Research Division Richard Tse - National Bank Financial, Inc., Research Division John Shuter - RBC Capital Markets, Research Division Michael Freeman - Raymond James Ltd., Research Division Kevin Krishnaratne - Scotiabank Global Banking and Markets, Research Division Presentation Unknown Executive Hi.

Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported a net loss attributable to Valhi stockholders of $22.2 million, or $.78 per share, in the third quarter of 2025 compared to net income of $57.5 million, or $2.01 per share, in the third quarter of 2024. For the first nine months of 2025, Valhi reported a net loss attributable to Valhi stockholders of $4.4 million, or $.15 per share, compared to net income of $85.2 million, or $2.99 per share, in the first nine months of 2024. Net income attributable to Valhi stockholders decreased in the third quarter and first nine months of 2025 as compared to the same periods in 2024 primarily due to lower operating results from the Chemicals Segment, a third quarter non-cash gain in 2024 related to the Chemicals Segment acquisition of the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) discussed below and an increase in the Company's tax expense due to legislation enacted in Germany during the third quarter of 2025, which resulted in a non-cash deferred income tax expense of $19.3 million ($12.8 million, or $.45 per share, net of noncontrolling interest).

Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on December 18, 2025 to stockholders of record at the close of business on November 21, 2025.

Dallas, Texas, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that, subject to the completion of quarter-end closing procedures, it expects to report third quarter 2025 earnings in a press release after market close on Thursday, November 6, 2025.

TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced that Novari Health (“Novari”), a VitalHub company, has been commissioned for its first UK deployment with the South West Provider Collaborative for its electronic referral and bed management workflow solution. The deployment will expand Novari's geographic footprint beyond current implementations in Canada and Australia.